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Hemodialysis with acetate, DL-lactate and bicarbonate: A hemody-
namic and gasometric study. Using invasive techniques we have studied
various hemodynamic and gasometric parameters in the course of hemo-
dialysis (HD) with different buffers in an animal model. HD sessions of
180 minutes at zero ultrafiltration were carried out on three groups of
eight uremic dogs each, under anesthesia and constant mechanical
ventilation. The three groups differed only in the buffer used: acetate
(Group AC), equal proportions of DL-lactate and acetate (Group
AC+LA), and bicarbonate (Group BC). No hemodynamic changes were
seen in Group BC. In the AC and AC+LA groups we observed on minute
1 a decrease of the mean blood pressure (MBP) and of the systemic
vascular resistances (SVR). These parameters returned to baseline values
within the first 30 minutes in Group AC+LA. In Group AC the SVR also
returned to baseline values after the minute 30, but the MBP remained
below baseline throughout the study period, together with cardiac index
and left ventricular stroke work index decreases. Only in Group AC did we
see a flattening of the ventricular function curves. Only in this Group was
there a decrease of the arterial oxygen pressure (Pa02) with an associated
increase of the alveolo-arterial and arterio-venous 02 differences. The 02
consumption was not modified in any of the groups. Acetate as a single
buffer induces hemodynamic instability through peripheral vasodilation
and reduction of myocardial contractility. The myocardial depression
induced by acetate, in its turn, causes a reduction in Pa02. The mixed
acetate-I-lactate buffer is hemodynamically better tolerated than acetate as
single buffer, as it induces only vasodilation.
In 1976, Novello, Kelsch, and Easterling described a complex of
hypotension, hyperacetatemia and intradialysis decrease of blood
bicarbonate in a group of chronic patients who they termed
"acetate-intolerant" [1]. It is generally accepted that acetate has a
peripheral vasodilating effect [2—7], but its actions on myocardial
contractility are still debated. For some authors acetate has a
myocardial depressant effect [7—11], for others it has no action
whatsoever [12], and for still others a physiological cardiac
response could be attributed to acetate's vasodilating effect, or
even a positive inotropic effect [3—6, 13, 14]. Acetate has also been
implicated as the cause of the hypoxemia frequently seen during
the hemodialysis (HD) session [15—18]. Alveolar hypoventilation
due either to CO2 loss in the dialysate [15, 16] or to a lower CO2
generation during acetate metabolism [17] and increased 02
consumption derived from acetate metabolism [18] are, among
others, some of the main mechanisms for the hypoxemia induced
by this buffer reported in the literature.
Bicarbonate would be the ideal buffer in HD, firstly because it
is the physiological buffer of the intercellular space and secondly
because it would not have the side effects attributed to acetate [2,
19]. This has led to HD with bicarbonate progressively replacing
that with acetate, particularly in high-efficiency HD, so that, at
present, 62% of all patients in Europe are dialyzed with bicarbon-
ate [20]. Nevertheless, and in spite of technological advances,
bicarbonate HD shows some disadvantages when compared with
acetate HD, such as its higher cost, greater technical problems
(precipitation in presence of calcium and magnesium), and stor-
age problems due to its tendency to decompose into CO2 and
water.
Other buffers, different from acetate and bicarbonate, have
been proposed for use in HD; among them, lactate has attracted
the greatest interest [21—24]. Thus, some clinical studies indicate
that use of lactate as a single buffer in the dialysis fluid is
associated to a lower incidence of symptoms as compared with
acetate, and that it is comparable to bicarbonate even in high-
efficiency HD [23]. Lactate, as single buffer in HD, also has some
disadvantages. High concentrations of lactate, such as those used
in HD fluids, tend to precipitate in the presence of calcium and
magnesium salts, particularly at cold temperatures, though to a
much lower degree than bicarbonate [23]. Also, high concentra-
tions of lactate in HD fluids may cause hyperlactatemia in some
patients, particularly those with hepatic dysfunction and even
more so in high-efficiency dialysis [23]. Mixtures of lactate and
acetate in HD fluids have been studied, which logically reduce the
amount of the former as compared to its use as single buffer and,
furthermore, prevent high lactate concentrations in the HD fluids
[21, 22, 24].
The aim of the present work was twofold: firstly, to study the
discrepancies present in the literature as to hemodynamic behav-
ior—particularly myocardial contractility—and oxygenation pa-
rameters in HD with acetate; secondly, to assess the hemody-
namic and gasometric response to HD with an equiproportional
mixture of acetate and lactate.
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Design of the experiment
HD was performed on 24 uremic dogs distributed in three
groups of eight dogs each. Dialysis characteristics were the same
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Acetate Acetate + Lactate Bicarbonate
MBP mm Hg 108.8 6.7 115.5 6.8 115.0 8.2
HR beats/mm 145 3.1 152 9.8 160 5.7
CI liter/min/m? 5.18 0.64 5.24 0.34 4.88 0.33
SI mI/beat/rn2 35.75 4.4 35.15 3.08 30.43 1.73
LVSWI g minIm2 53.42 7.47 55.64 6.08 48.05 4.60
MPAP mm Hg 14,17 1.26 14.5 0.95 14.12 1.06
CVP rum Hg 5.62 0.98 6.37 0.62 6.25 0.77
PCWP mm Hg 6.87 0.91 7.25 0.86 7.12 0.72
SVR dynes s/cm5
PVR dynes s/cm5
2106 265
151.9 28.46
1962 245
128.7 15.29
2211 164
140.8 18.06
SI/PCWP 5.6 0.61 5.3 0.47 4.44 0.29
LVSWI/PCWP 8.1 0.80 7.84 0.52 6.78 0.39
Data are means SEM. None of the baseline values differed significantly
from each other. Abbreviations are: MBP, mean blood pressure; HR,
heart rate; CI, cardiac index; SI, stroke index, LVSWI, left ventricular
stroke work index; MPAP, mean pulmonary arterial pressure; CVP,
central venous pressure; PCWP, pulmonary capillary wedge pressure;
SVR, systemic vascular resistance; PVR, pulmonary vascular resistance.
in all cases, but for the buffer used: in Group AC acetate was used
as the only buffer; in Group AC+LA an equiproportional mixture
of acetate and DL-lactate was used; and in Group BC bicarbonate
was the single buffer. All dialyses lasted for 180 minutes, with zero
ultrafiltration and at identical dialysate temperatures. The ani-
mals were under general anesthesia and constant mechanical
ventilation. Hemodynamic parameters were assessed by invasive
techniques.
Preparation of the animals
All the studies were carried out in dogs in which liver disease
had been previously ruled out (normal levels of alkaline phos-
phatase, total bilirubin, ALAT, ASAT and LDH). The mean
weight of the animals was 24.7 2.28 kg in Group AC, 27.6
1.68 kg in Group AC+LA, and 24.1 1.39 kg in Group BC
(intergroup differences non-significant). Acute renal failure was
induced in all animals through bilateral ureteral ligation 48 hours
before HD, under antibiotic prophylaxis with gentamicin 3 mg/kg
and cephazolin 250 mg (i.v.).
Anesthesia was induced with pentothal sodium 10 mg/kg Lv.,
pancuronium bromide 0.07 mg/kg i.v., and fentanyl 1 jig/kg i.v.; an
orotracheal tube was then inserted and ventilation initiated with
an Engstrom ER 300 volumetric respirator (LKB Medical AB,
Broma, Sweden), using a gas mixture of 40% oxygen and 60%
nitrous oxide and a tidal volume of 12 mI/kg body wt. The
respiratory rate was adjusted to maintain a baseline arterial CO2
pressure (PaCO2) of ca. 35 mm Hg; after reaching that PaCO2,
the respirator's parameters were kept constant during the study.
Spontaneous ventilation was prevented with pancuronium bro-
mide, 0.04 mg/kg/hr i.v., which was used upon early detection of
decurarization signs through the corneal reflex.
Dialysis procedures
The composition of the dialysis fluids was: for Group AC, Na
138 mmol/liter, K 1.5 mmol/liter, Ca 1.75 mmol/liter, Mg 0.75
mmol/liter, Cl 109 mmol/liter, glucose 1 g/liter, and acetate 35
mmol/liter; for Group AC+LA the composition was the same, but
for acetate 17.5 mmol/liter and DL-lactate 17.5 mmol/liter as
buffer; for Group BC the composition was Na 139 mmol/liter, K
1.5 mmol/liter, Ca 1.75 mmol/liter, Mg 0.5 mmol/liter, Cl 106
mmol/liter, glucose 1.5 g/liter, theoretical bicarbonate 39 mmol/
liter, bicarbonate measured at the time of HD 34.52 0.44
mmol/liter, and acetate 4 mmol/liter.
An HD device with volumetric ultrafiltration control was used
(Toray TR-321, Toray Medical Co. Ltd., Tokyo, Japan). The
vascular access for HD was through the femoral vein and artery
with pediatric lines (Gambro Dialysatoren GmbH & Co. KG,
Hechingen, Germany) and with catheters inserted through one
cutdown. We chose a biocompatible polyacrylonitrile membrane
to prevent the gasometric changes induced by bioincompatible
cellulosic membranes (Filtral 8, Hospal Industrie, Meyzieu,
France). The dialysate temperature was 37.5°C for all HDs. The
blood flow was 8 ml/kg/min, and the dialysis fluid flow 500 ml/min.
Hemodynamic monitorization
For blood pressure measurements, the contralateral femoral
artery was dissected and canalized with a Seldicath 3876 E
catheter (Laboratoire Pharmaceutique, Saint-Leu-la-Fôret Ce-
dex, France); a pulmonary artery was canalized through the
dissected femoral vein (also contralateral to the HD access) with
an Elecath 73-6067 Swan-Ganz catheter with thermistor (Electro-
Catheter Corporation, Rahway, New Jersey, USA). The systemic
arterial, pulmonary arterial, and right atrial pressures were re-
corded in a Lifescope 6 monitor (Nihon Kohden Corporation,
Tokyo, Japan). The heart rate (HR) was derived from Lead II of
the ECG. The cardiac output (CO), expressed in liter/mm, was
measured by thermodilution with an Elecath COC 4000 com-
puter. Three successive measurements were carried out and the
mean was accepted. Measurements were performed at timepoints
0, 1, 5, 15, 30, 45, 60, 90, 120, 150, and 180 (minutes after starting
HD). At each timepoint, mean blood pressure (MBP), mean
pulmonary artery pressure (MPAP), central venous pressure
(CVP), pulmonary capillary wedge pressure (PCWP) (all in mm
Hg), HR and CO were recorded; from these, and for the same
timepoints, the following were calculated according to the formu-
lae given [25]:
1. Cardiac index (CI) = CO/body surface area (1/mm/rn2).
2. Stroke volume (SV) CO• 1000/HR (ml/beat).
3. Stroke index (SI) = SV/body surface area (mI/beat/rn2).
4. Left ventricular stroke work index (LVSWI) = SI MBP
0.0136 (g min/m2).
5. Systemic vascular resistance (SVR) = (MBP — CVP) 79.9/CO
(dynes . s/cm5).
6. Pulmonary vascular resistance (PVR) = (MBP — PCWP) . 79.9/
CO (dynes . s/cm5).
The SI/PCWP and LVSWI/PCWP ratios were also calculated for
the same timepoints. Power curves and linear regression equa-
tions were determined from individual values of LVSWI and
PCWP to obtain left ventricular function curves [26].
Laboratory methods
At timepoints 0, 60, 120 and 180 the plasma levels of acetate
(gas chromatography, as previously described [27]) and L-lactate
(enzymatic method [28]) were determined. Acetate balance was
evaluated after measuring total dialysate recovered in a calibrated
tank. Predialyzer and dialysate acetate were measured by tripli-
cate and the mean was accepted. From that data the final acetate
balance was extrapolated. At timepoints 0 and 180 arterial blood
samples were withdrawn for measurement of hemoglobin (Hb),
Table 1. Hemodynamic baseline values
hematocrit, osmolality, sodium, potassium, calcium and BUN.
The depuration efficiency of the dialysis was assessed according to
the formula KTIV = ln (BUN mm 0/BUN mm 180). At time-
points 0, 5, 15, 60, 90, 120, 150 and 180 samples were taken for
gasometsy in arterial blood (intraluminal catheter) and mixed
venous blood (distal lumen of the Swan-Ganz catheter). For each
gasometric measurement 1 ml blood was withdrawn into a hepa-
rinized plastic syringe which was anaerobically closed and trans-
ported on ice for immediate processing in a Ciba-Corning 278
blood gas analyzer (Ciba-Corning Diagnostics Corporation, Med-
field, Massachusetts, USA). For these timepoints the following
oxygenation parameters were calculated [29}:
7. PAO2 = [(703 — 47) . Fi02] — PaCO2 (mm Hg).
8. P(A-a)02 = PAO2 — Pa02 (mm Hg).
9. CcO = (ITh 1.39) + PAO2 0.0031 (vol%).
10. CaO (hF3. 1.39 Sa02) + Pa02 . 0.003 1 (vol%).
11. CvO = (Hb. 1.39 Sv02) +Pv02 0.0031 (vol%).
12. C(a-v)02 = Ca02 — Cv02 (vol%).
13. Qs/Qt = CeO2 — Ca02/Cc02 — Cv02
14. DO2 = Ca02 CO/body surface area (ml O2Imin/m2).
15. V02 = D(a-v)02 CO/body surface area (ml 02/min/m2).
where PAO2 is the alveolar oxygen pressure, 703 (mm Hg) the
mean barometric pressure in Madrid, 47 (mm Hg) the water vapor
pressure, Fi02 the inspired oxygen fraction, PaCO2 (mm Hg) the
partial arterial carbon dioxide, Pa02 the partial arterial oxygen
pressure, Cc02, Ca02 and Cv02 the oxygen contents in pulmo-
nary capillary, arterial and mixed venous blood, respectively, Sa02
and Sv02, the oxygen saturation of hemoglobin in arterial and
mixed venous blood, respectively, C(a-v)O2 the arterio-venous
oxygen content difference, Qs/Qt the right-to-left shunt, DO2 the
tissue oxygen supply, and VO2 the oxygen consumption.
Statistics
Differences between variables were analyzed by the Student's
and ANOVA tests. Pearson's correlation coefficient (r) was
computed to test the association between pairs of variables. The
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Fig. 1. Hemodynamic changes. Symbols are: (-El-) acetate; (-•-) acetate+lactate; (-h-) bicarbonate. Asterisks denote statistically significant differences
versus minute 0: * < ØØ5. **p < 0.001; *** < 0.001.
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Fig. 2. Hemodynamic changes. Abbreviations are: SI, stroke index; LVSWI, left ventricular stroke work index; PCWP, pulmonary capillary wedge
pressure. Symbols are as in Figure 1.
null hypothesis was rejected when P < 0.05. All values are
expressed as arithmetic means SEM.
Results
Hemodynamic parameters
Table 1 summarizes the baseline hemodynamic values. No
intergroup differences were observed. Figure 1 shows the course
over time for MBP, CI, HR and SVR. It can be seen that in
Groups AC and AC+LA there was, in the first minute of HD, a
decrease of MBP and SVR, with an increase of CI and HR. In
Group AC+LA these parameters returned to baseline levels as
from minute 30 of HD. In Group AC SVR also returned to
baseline values as from minute 30, but MBP remained low up to
the end of the procedure. After the first few minutes of HD with
acetate as single buffer there was a decrease of CI, which was
significant as from minute 60 and maximal (25.9 5.1%) on
minute 150 (P < 0.01). In this group HR remained increased as
compared to baseline up to minute 120. We only observed a
decrease of SI and LVSWI, and of the SIIPCWP and LVSWII
PCWP ratios in Group AC (Fig. 2). Figure 3 shows the course
over time for CVP, PCWP, MPAP and PVR.
Intergroup differences. MBP decreased significantly in Group
AC as compared to Group BC on minutes 1, 5, 15 and from
minute 90 of HD onwards (P < 0.01), and as compared to Group
AC+LA from minute 90 onwards (P < 0.05). However, there
were no differences in MBP between Groups AC+LA and BC
throughout the study. SVR decreased in Groups AC and AC+LA
as compared to Group BC on minutes 1 and 5 of HD (P < 0.01),
but differences between Group AC and Group AC+LA only
existed on minute 1 (P < 0.05). The CI decreased significantly in
Group AC as compared to Groups AC+LA and BC from minute
120 onwards (P < 0.05). The SI and LVSWI decreased in Group
AC as compared to Group BC as from minutes 45 (P < 0.05) and
as compared to Group AC+LA as from minute 90 (P < 0.05).
These intergroup differences persisted when comparing the SI!
PCWP and LVSWI!PCWP ratios. There were no significant
intergroup variations in HR, nor when comparing Group AC+LA
and Group BC, in CI, SI, LVSWI, SIIPCWP or LVSWI/PCWP.
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Fig. 3. Hemodynamics changes. Abbreviations are: CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure; MPAP, mean pulmonary
artery pressure; PVR, pulmonary vascular resistances. Symbols are as in Figure 1.
Upon analysis of the ventricular function curves we observed a
significant baseline correlation between LVSWI and PCWP in all
three groups (Fig. 4). It can be seen that on minute 180 this
correlation was lost only in the group dialyzed with acetate as
single buffer. The slopes of the regression lines constructed on
minutes 0 and 180 were similar for groups AC+LA and BC, and
significantly different for Group AC (P < 0.05; Fig. 4).
Acetate an4 L-lactate values
In Group AC the mean maximal plasma acetate level, which
had been achieved by minute 180, was 4.67 0.67 mmol/liter, the
highest individual value being 8.1 mmol/liter (Fig. 5); there was an
inverse correlation between the weights of the animals and the
plasma acetate levels (r =
—0.76, P < 0.05). In Group AC+LA
the highest mean maximal acetate level was 1.15 0.08 mmollliter
on minute 60. The plasma acetate levels were significantly higher
in Group AC as compared with Group AC+LA on minutes 60,
120 and 180 (P < 0.001). The acetate absorption through the
dialyzer in Group AC was 144.9 7.9 mmol/hr (6.17 0.43
mmol/kglhr), while in Group AC+LA it was 79.5 4.8 mmol/hr
(2.99 0.13 mmol/kg/hr) (P < 0.001). An inverse correlation was
observed in Group AC between acetatemia and the LVSWI/
PCWP ratio already from minute 60 (r =
—0.83, P < 0.05).
There were no differences in the baseline plasma L-lactate
levels between the three groups (Fig. 5). The L-lactate levels
increased during HD only in Group AC+LA; this increase was
statistically significant as compared with Groups AC and BC (P <
0.01).
Hematocrit and other laboratory data
As shown in Table 2, there were no variations in the hematocrit
or the sodium levels during HD in any of the three groups. The
depuration efficiency of HD, estimated through the KT/V, was
similar for all three. The decrease in osmolality and potassium and
the increase in calcium showed no intergroup differences.
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There were no differences between the three groups in the
baseline values of HC03, PaCO2, and pH (Table 3). The
increase of HCO3 was significantly greater (P < 0.01) in Group
BC as compared with Groups AC and AC+LA from minute 5 of
HD onwards (Fig. 6). The HCO3 increase was not significantly
different between Groups AC and AC+LA, although it appeared
earlier in the latter. In Group BC there was an increase in PaCO2
from minute 15 of HD onwards, while this parameter showed no
variations in Group AC+LA and decreased in Group AC (Fig. 6).
Although the pH increased more in Group BC, the intergroup
differences did not reach statistical significance (Fig. 6).
There were no significant baseline differences between the
groups in Pa02, P(A-a)02, C(av)O2, DO2, V02 or QsfQt, as
shown in Table 3; the evolution of these parameters is illustrated
in Figure 7. The Pa02 decreased only in Group AC from minute
60 of HD, with a mean maximal decrease of —9.61 2.15% on
minute 180 (P < 0.01). This decrease became significant as
compared to Group AC+LA from minute 90 (P < 0.05), and as
compared to Group BC from minute 150 (P < 0.05). In Group
Fig. 4. Ventricular function curves. Relationship between left ventricular
stroke work index (LVSWI) and pulmonary capillary wedge pressure(PCWP). The regression lines are plotted from all the individual data at
minute 0 (•) and at minute 180 (0). In the acetate group (A) these varied
from y = 6.28x + 10.18 to y = 0.91x + 18.81 (P < 0.05), in the
acetate+lactate group (B) from y = 6.lOx + 11.37 to y = 5.15x + 13.12
(NS), and in the bicarbonate group (C) from y = 5.49x + 8.95 toy = 5.30x
+ 843 (NS).
AC the decrease in Pa02 was associated with a fall of Pv02, with
peak decrease by minute 180 (from 62.02 2.66mm Hg at minute
0 to 45.58 2.99 mm Hg at minute 180, P < 0.001). The increase
in P(A-a)02 in Group AC became significant (P < 0.05) as
compared to the other two groups on minute 150, and that of
C(a-v)02 on minute 120 (P < 0.05). The DO2 decrease in Group
AC became significant as compared to the other two groups from
minute 120 (P < 0.05). The V02 did not show significant
variations in any of the three groups, and the Qs/Qt decreased in
all three (Fig. 7).
Discussion
Our data show that in HD with acetate as the only buffer,
marked hemodynamic changes arose, consisting of initial periph-
eral vasodilation followed by a decrease in cardiac output, with a
blood pressure decrease over the complete dialysis session. The
vasodilator effect of acetate is well-known [2—7], yet very few
authors report the onset of this effect as early as seen in our study
[4, 5]. Keshaviah et al [4] observed a decrease of SVR and of
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Fig. 5. Blood acetate and L-lactate levels. Symbols are as in Figure 1.
blood pressure in the first minute of acetate infusion in non-
uremic, anesthetized dogs. Daugirdas, Nawad, and Hayashi [5]
also observed peripheral vasodilation in the first minute of HD
with acetate in non-uremic dogs. In both studies, after a few
minutes there was a "rebound" effect of SVR recovery, which was
complete when the animals had been previously subjected to
chemical sympathectomy [5]. The mechanisms of this recovery are
unknown, but the authors speculate that increased levels of
vasoactive hormones or metabolic adaptation to the action of
acetate might be some of the implicated mechanisms [5]. A
recovery of SVR was also observed in our study, and as is the case
in other reports [4, 5], the mechanism is unknown. In our study,
the smaller decrease of SVR in the first minute of HD in Group
AC+LA as compared to Group AC could be due, on the one
hand, to the smaller amount of acetate provided in the former,
and on the other hand to a lesser vasodilator effect of lactate as
compared to acetate [30]. In both groups, AC and AC+LA, there
was an increase in heart rate and cardiac index in the first minute
of HD; both these increases are physiologic mechanisms of
compensation of the vasodilator effect [3—6].
Acetate Acetate + Lactate Bicarbonate
KT/V 1.01 0.06 1.02 0.03 1.11 0.07
Sodium mmol/liter
Minute 0 138.0 1.0 137.4 0.88 137.1 1.18
Minute 180 136.3 0.32 136.2 0.36 136.1 0.23
Osmolality mOsm/kg H20
Minute 0 335.1 3.71 330.9 5.35 330.6 4.46
Minute 180 301.7 309b 301.8 3.65" 299.1 2.66"
Calcium mg/dl
Minute 0 8.72 0.21 9.10 0.26 8.66 0.45
Minute 180 10.41 0.20" 10.33 0.20 9.92 027b
Potassium mmol/liter
Minute 0 5.00 0.45 4.88 0.35 5.61 0.51
Minute 180 3.28 0.19 3.34 0.18 3.50 0.12
Hematocrit %
Minute 0 36.95 2.57 33.81 2.15 35.90 2.47
Minute 180 38.42 2.59 34.21 2.30 36.14 2.80
Acetate Acetate+Lactate Bicarbonate
PH 7.260 0.02 7.222 0.02 7.249 0.04
PaCO2 mm Hg 35.40 1.90 35.64 1.51 37.08 2.35
HCO> mmol/liter 15.56 0.28 14.69 0.37 16.38 1.11
Pa02 mm Hg 167.0 7.27 153.3 8.14 177.2 12.01
P(A-a)02 mm Hg 58.73 7.43 72.28 8.20 46.88 11.79
C(a-v)02 vol%
DO> ml 02/min/m2
V02 ml 0>/minIm2
2.33 0.22
951.8 155.1
118.73 15.70
2.62 0.27
862.3 88.6
136.61 15.35
2.97 0.46
842.5 103.6
141.01 19.52
QsIQt % 14.34 1.77 14.95 1.87 11.80 2.97
Data are means SEM. None of the baseline values differed significantly
from each other. Abbreviations are: PaCO2, Partial pressure of arterial
carbon dioxide; Pa02, Partial pressure of arterial oxygen; P(A-a)02,
Alveolo-arterial oxygen pressure difference; C(a-v)O>, Arterio-venous
oxygen content difference; DO>, Tissue oxygen supply; VO>, Oxygen
consumption; QsIQt, Right-to-left shunting.
After the first few minutes, the evolution of the hemodynamic
parameters showed marked differences between the groups.
While in Groups AC+LA and BC there were no significant
changes, in Group AC there was a decrease of CI, SI and MBP,
with a reduction of the LVSWI only in this group. The cardiac
performance is dependent on the preload, the afterload, the heart
rate and the contractile capacity of the myocardium [31]. In our
case, and as regards Group AC, we can rule out changes in the
preload, as neither the CVP (which expresses the end-diastolic
filling pressure of the right ventricle) nor the PCWP (which
expresses that of the left ventricle) varied during the study.
Similarly, an increase of the afterload (which would have a
negative influence on myocardial contractility) can also be ruled
out, as the SVR were not different from the baseline ones in these
stages of HD or even showed a trend to decrease. As neither the
preload nor the afterload varied, the decrease in SI in Group AC
must have been due to a reduction of the myocardial contractility
together with the increased heart rate. In the absence of compen-
satory vasoconstriction, the increase in HR would be the only
available mechanism to maintain cardiac output against a negative
A Table 2. Analytical data
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Table 3. Gasometric baseline values
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inotropic effect, as already reported [9, 31]. The blood pressure
decrease in Group AC after the initial minutes of the study was
caused by the decrease in cardiac output without variations in
SVR or CVP. The myocardial depression in this group is evident
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in the flattening of the ventricular function curves, that is, in the
loss of the correlation between LVSWI and PCWP during dialysis.
The reduction of the SI/PCWP and LVSWI/PCWP ratios in this
group further indicates a reduction of myocardial contractility [6].
In the present study, the negative correlation between plasma
acetate levels and the LVSWIIPCWP ratio in Group AC suggests
a negative effect of acetate on myocardial contractility during the
dialysis session. The negative relationship at minute 60 did not
increase at minutes 120 and 180, perhaps because the depressor
effect of acetate was already near its maximal activity. In vitro
studies have shown that acetate has a vasodilating [30, 32] and a
myocardial depressant [33] effect, both of them at concentrations
normally achieved in HD. Both the vasodilation and the myocar-
dial depression could arise as a consequence of the formation of
intermediate metabolites. This so-called metabolic theory of the
acetate action was first proposed by Liang and Lowenstein [3]
who, during acetate infusion in dogs, observed increased tissue
levels of adenosine and adenosine monophosphate (AIVIP), and
postulated that vasodilation could be due to the action of aden-
osine generated from AMP by the action of the enzyme 5-nude-
** otidase. Daugirdas and Nawad [32] have reported that the vaso-
dilator effect arose during the formation of AMP. The same
-
- authors, in another study, [33] postulated that the myocardial
depressant effect of acetate could be due to the action of
adenosine, as this has been shown to have a negative inotropic
effect on tissue samples isolated from the atria or the papillary
muscles [34]. It is possible that, in our own study, no negative
inotropic effect was observed in Group AC+LA because both the
amount of acetate provided and the plasma acetate levels
achieved were low. However, we do not know the possible role of
lactate, to which both cardiostimulating [35] and cardiodepressant
[36] actions have been attributed.
90 120 150 180 In the present study, only Group AC showed a reduction in
Pa02. The main mechanism of hypoxemia caused by the use of
acetate in the dialysis fluid is alveolar hypoventilation [15—17]. In
our case, the fall in Pa02 in Group AC occurred in the absence of
hypoventilation, as the animals were under constant mechanical
ventilation, Studies performed both in humans [37] and in dogs
[38], also under general anesthesia and mechanical ventilation,
have failed to show changes in Pa02 during HD with acetate. In
contrast, other authors report reductions in Pa02 in patients
dialyzed with acetate under mechanical ventilation [39, 40]. The
causes of these discrepancies are probably to be found in differ-
ences in the populations studied, in the biocompatibility of the
membranes used, in the efficiency of the dialysis (and thus in the
amount of acetate provided), and in the hemodynamic perfor-
mance during HD. In our study we used a biocompatible mem-
brane which has been shown to have no influence on Pa02 nor on
pulmonary hemodynamics [15, 41]; furthermore, the anesthetic
procedure was the same for all three groups. It could be surmised
that, in Group AC, adenosine derived from the metabolism of
acetate might have been the cause of the drop in Pa02, either
through its bronchoconstrictive action [42] or through an alter-
ation of pulmonary hemodynamics [43]. We did not measure
pulmonary airflow resistances, although indirect data suggest that
bronchoconstriction, if at all present, must have been slight, as
bronchoconstriction increases the intrapulmonary shunt [29], and
this was actually decreased. There were also no changes in PVR.
The increase in MPAP only during the first five minutes of HD in
groups AC and AC+LA might have been a consequence of the
0.2
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Fig. 6. Arterial acid-base balance values, PaCO2 is arterial partial carbon
dioxide pressure. Symbols are as in Figure 1.
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increased cardiac output, itself a consequence of peripheral
vasodilation [51. In Group AC an increase in P(A-a)02 was seen,
suggesting a ventilation/perfusion impairment, together with and
increase in C(a-v)02, both of which may be caused by a decrease
in cardiac output [29]. A reduction of Pv02 appears when the
tissue oxygen extraction increases, and this happens in such widely
different situations as sudden anemia, increased metabolism with
increase of oxygen uptake, and reduction of cardiac output [29].
In our study, anemia did not arise in any of the groups, nor were
there significant changes in oxygen consumption. Based on these
data, we consider that the Pa02 decrease in Group AC was due
primordially to a fall in cardiac output, as it is well-known that a
reduction in this parameter typically induces a slight drop in Pa02,
because when the cardiac output decreases, the shunted blood
entering the arterial circulation will have a lower Pv02 than while
it was normal [29].
Changes in sodium and osmolality [44], as well as in potassium
and calcium [45], may modify myocardial contractility during HD.
In the present study, however, it is improbable that variations in
these parameters may have had an influence on the reduction of
myocardial contractility in Group AC, as there were no significant
changes in the sodium levels, and the decreases in plasma
osmolality and plasma potassium, and the rise in the calcium
levels were similar in all three groups.
Some authors have reported that changes in the acid-base
balance during HD with acetate might act as adjuvant to the
latter's effect as a depressant of myocardial contractility [11]. Both
a worsening of metabolic acidosis [1] and hypocapnia [15—17] may
occur during HD with acetate, and both have a negative inotropic
effect [46]. In view of constant mechanical ventilation, the PaCO2
fall in Group AC must be a consequence either of CO2 loss into
dialysate [15, 16] or of a lower CO2 generation during acetate
metabolism [17]; in this group, we cannot rule out that the
reduction of PaCO2 might have negatively influenced myocardial
contractility, although the PaCO2 reduction, though significant,
was slight. The PaCO2 did not change in Group AC+LA, even
though the CO2 losses into the dialysate were probably similar to
those seen in Group AC. This finding agrees with a previous
observation in patients with chronic renal failure when a dialysis
fluid with the same composition was used [24]. Several factors
might have been at the origin of the divergent evolution of PaCO2
in Groups AC and AC+LA. In the first place, it is well-known that
CO2 production during metabolism of lactate is twice that seen
during metabolism of acetate [35, 47, 48]; a further possibly
contributing factor may have been bicarbonate hydrolysis, as the
rise of the blood bicarbonate levels occurred earlier and, even
though it did not achieve statistical significance, tended to be
slightly higher in Group AC+LA.
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Fig. 7. Oxygenation parameters. Abbreviations
are: Pa02, arterial partial oxygen pressure;
P(A-a)02, alveolo-arterial oxygen pressure
difference; C(a-v)02, arterio-venous oxygen
content difference; Qs/Qt, right-to-left shunt;
DO2, tissue oxygen supply; V02, oxygen
consumption. Symbols are as in Figure 1.
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With the use of AC+LA concentrate the plasma levels both of
acetate and of L-lactate were low. Acetate is metabolized mainly
in striated muscle and to a lesser proportion in the liver [47], while
lactate is metabolized to a greater extent in the liver, and to a
lesser one in muscle [48]; furthermore, the metabolic pathways
are different for both anions [47, 48]. This renders it possible to
use simultaneously acetate and lactate in hemodialysis fluids as,
within the organism, they will be transformed complementarily
through metabolic pathways and in tissues for neutralization of
hydrogenions. In theory, the acetate-lactate mixture would offer
advantages over acetate as single buffer when, with the latter, the
maximal rate of acetate metabolism is widely exceeded; this
occurs mainly in high-efficiency HD and/or with patients having a
low muscular mass [47]. When this happens, a progressive in-
crease of the plasma acetate levels is seen during the HD session,
while at the same time the metabolism of the anion insufficiently
compensates the bicarbonate losses into the dialysate [47]. We
think that, in our study, the maximal rate of acetate metabolism
was only exceeded in Group AC. This would explain the differ-
ences in the plasma acetate levels between Group AC and Group
AC+LA, as well as the evolution of the blood bicarbonate levels,
although it is well-known that lactate conversion into bicarbonate
is slower than that of acetate [23, 35].
In summary, even though we acknowledge that this experimen-
tal model cannot be fully extrapolated to chronic patients on HD,
we have ascertained that acetate as the single buffer may induce
hemodynamic instability through peripheral vasodilation and de-
pression of myocardial contractility. Even in the absence of
hypoventilation, acetate may cause a fall in the arterial oxygen
pressure, through a reduction in cardiac output. The equipropor-
tional mixture of acetate and lactate also induces vasodilation, but
demonstrates advantages over acetate as single buffer in that it
does not cause myocardial depression and thus does not modilS'
the arterial oxygen pressure through this mechanism.
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